Denali Therapeutics Inc. (DNLI) Total assets 2017–2025
Denali Therapeutics Inc. (DNLI) total assets at each fiscal year-end, per SEC filings.
$1.1BFY2025 · since FY2017: $486.7M → $1.1B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $1.1B | -16.7% |
| FY2024 | $1.4B | +19.1% |
| FY2023 | $1.2B | -21.0% |
| FY2022 | $1.5B | +4.0% |
| FY2021 | $1.4B | -12.5% |
| FY2020 | $1.6B | +190.0% |
| FY2019 | $553.2M | -16.4% |
| FY2018 | $662.0M | +36.0% |
| FY2017 | $486.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice